Not Signed In - All Topic Areas
1 - 10 of 13 more >>
News
1 - 2 of 2
- Barr Confirms Patent Challenge Of Razadyne(R) ER Capsules
MedicalNewsToday - Sat, 08 Jul 2006 06:00 EST
- Mild/Moderate Alzheimer's Disease, Razadyne™ ER, New Once-Daily Treatment Option, Now Available
MedicalNewsToday - Tue, 24 May 2005 04:00 EST
Clinical Trials
1 - 5 of 5
- Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00027677 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Topical Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00064142 - Active, not recruiting
epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
- Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study
ClinicalTrials.gov Identifier: NCT00216593 - Active, not recruiting
Dementia; Alzheimer Disease
- A Study of the Safety and Effectiveness of Galantamine Hydrobromide (REMINYL®) in Patients With Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00297362 - Completed
Brain Diseases; Alzheimer Disease; Mental Disorders; Nervous System Diseases; Dementia
- Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
ClinicalTrials.gov Identifier: NCT00176540 - Completed
Fatigue; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
email this page
print this page
bookmark this page
feedback on this page
